Short telomere length, lung function and chronic obstructive pulmonary disease in 46 396 individuals

Thorax

Volumn 68, Issue 5, 2013, Pages 429-435

  Rode, Line ^a   Bojesen, Stig E ^a,b,c   Weischer, Maren ^a,c   Vestbo, Jørgen ^d,e   Nordestgaard, Børge G ^a,b,c  

^a GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^b BISPEBJERG HOSPITAL   (Denmark)

^c UNIVERSITY OF COPENHAGEN   (Denmark)

^d UNIVERSITY OF MANCHESTER   (United Kingdom)

^e UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

DNA;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; DENMARK; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; FEMALE; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HUMAN; HUMAN CELL; LEUKOCYTE; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; MOLECULAR PATHOLOGY; OBSERVATIONAL STUDY; PRIORITY JOURNAL; REFERENCE VALUE; SPIROMETRY; TELOMERE SHORTENING;

EID: 84876290428     PISSN: 00406376     EISSN: 14683296     Source Type: Journal    
DOI: 10.1136/thoraxjnl-2012-202544     Document Type: Article

References (30)

1. Rahman I. The role of oxidative stress in the pathogenesis of COPD: implications for therapy. Treat Respir Med 2005;4:175-200. (Pubitemid 41018366)
2. Donate LE, Blasco MA. Telomeres in cancer and ageing. Philos Trans R Soc Lond B Biol Sci 2011;366:76-84.
3. Stewart SA, Weinberg RA. Telomeres: cancer to human aging. Annu Rev Cell Dev Biol 2006;22:531-57.
4. Shammas MA. Telomeres, lifestyle, cancer, and aging. Curr Opin Clin Nutr Metab Care 2011;14:28-34.
5. von Zglinicki T. Oxidative stress shortens telomeres. Trends Biochem Sci 2002;27:339-44. (Pubitemid 34756516)
6. Cherkas LF, Aviv A, Valdes AM, et al. The effects of social status on biological aging as measured by white-blood-cell telomere length. Aging Cell 2006;5:361-5. (Pubitemid 44322531)
7. Valdes AM, Andrew T, Gardner JP, et al. Obesity, cigarette smoking, and telomere length in women. Lancet 2005;366:662-4. (Pubitemid 41176019)
8. von Zglinicki T, Martin-Ruiz CM. Telomeres as biomarkers for ageing and age-related diseases. Curr Mol Med 2005;5:197-203. (Pubitemid 40601647)
9. Cassidy A, De Vivo I, Liu Y, et al. Associations between diet, lifestyle factors, and telomere length in women. Am J Clin Nutr 2010;91:1273-80.
10. Vestbo J, Hurd SS, Agusti AG, et al. Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease, GOLD executive summary. Am J Respir Crit Care Med Published Online First: 9 Aug 2012. doi: 10.1164/rccm.201204-0596PP
11. 1/FVC ratio reduces the misclassification of airway obstruction. Thorax 2008;63:1046-51.
12. Baekvad-Hansen M, Dahl M, Tybjaerg-Hansen A, et al. Surfactant protein-B 121ins2 heterozygosity, reduced pulmonary function, and chronic obstructive pulmonary disease in smokers. Am J Respir Crit Care Med 2010;181:17-20.
13. Dahl M, Bowler RP, Juul K, et al. Superoxide dismutase 3 polymorphism associated with reduced lung function in two large populations. Am J Respir Crit Care Med 2008;178:906-12.
14. Nordestgaard BG, Palmer TM, Benn M, et al. The effect of elevated body mass index on ischemic heart disease risk: causal estimates from a Mendelian randomisation approach. PLoS Med 2012;9:e1001212.
15. Dahl M, Tybjaerg-Hansen A, Lange P, et al. Change in lung function and morbidity from chronic obstructive pulmonary disease in alpha1-antitrypsin MZ heterozygotes: a longitudinal study of the general population. Ann Intern Med 2002;136:270-9. (Pubitemid 34150756)
16. Juul K, Tybjaerg-Hansen A, Mortensen J, et al. Factor V leiden homozygosity, dyspnea, and reduced pulmonary function. Arch Intern Med 2005;165:2032-6. (Pubitemid 41362628)
17. Kaur-Knudsen D, Nordestgaard BG, Bojesen SE. CHRNA3 genotype, nicotine dependence, lung function and disease in the general population. Eur Respir J 2012;40:1538-44.
18. Cawthon RM. Telomere length measurement by a novel monochrome multiplex quantitative PCR method. Nucleic Acids Res 2009;37:e21.
19. Weischer M, Bojesen SE, Cawthon RM, et al. Short telomere length, myocardial infarction, ischemic heart disease, and early death. Arterioscler Thromb Vasc Biol 2012;32:822-9.
20. Bestall JC, Paul EA, Garrod R, et al. Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease. Thorax 1999;54:581-6. (Pubitemid 29296676)
21. Aoshiba K, Nagai A. Senescence hypothesis for the pathogenetic mechanism of chronic obstructive pulmonary disease. Proc Am Thorac Soc 2009;6:596-601.
22. Amsellem V, Gary-Bobo G, Marcos E, et al. Telomere dysfunction causes sustained inflammation in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2011;184:1358-66.
23. Tsuji T, Aoshiba K, Nagai A. Alveolar cell senescence in patients with pulmonary emphysema. Am J Respir Crit Care Med 2006;174:886-93. (Pubitemid 44564788)
24. Alder JK, Guo N, Kembou F, et al. Telomere length is a determinant of emphysema susceptibility. Am J Respir Crit Care Med 2011;184:904-12.
25. Savale L, Chaouat A, Bastuji-Garin S, et al. Shortened telomeres in circulating leukocytes of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2009;179:566-71.
26. Houben JM, Mercken EM, Ketelslegers HB, et al. Telomere shortening in chronic obstructive pulmonary disease. Respir Med 2009;103:230-6.
27. Morla M, Busquets X, Pons J, et al. Telomere shortening in smokers with and without COPD. Eur Respir J 2006;27:525-8. (Pubitemid 43372526)
28. Mui TS, Man JM, McElhaney JE, et al. Telomere length and chronic obstructive pulmonary disease: evidence of accelerated aging. J Am Geriatr Soc 2009;57:2372-4.
29. Lee J, Sandford AJ, Connett JE, et al. The relationship between telomere length and mortality in Chronic Obstructive Pulmonary Disease (COPD). PLoS One 2012;7: e35567.
30. Celli BR, Cote CG, Marin JM, et al. The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med 2004;350:1005-12. (Pubitemid 38269277)